Karen-Leigh Edwards
Chief Tech/Sci/R&D Officer chez OCULAR THERAPEUTIX, INC.
Profil
Karen-Leigh Edwards is currently the Senior Vice President-Technical Operations at Ocular Therapeutix, Inc. She previously worked as the Head-External Manufacturing & Operations at Alexion Pharmaceuticals, Inc. Edwards has a graduate degree from the University of London, a doctorate from the University of Kansas, and an undergraduate degree from the University Of The West Indies.
She also holds an MBA from the MIT Sloan School of Management.
Postes actifs de Karen-Leigh Edwards
| Sociétés | Poste | Début |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Chief Tech/Sci/R&D Officer | 28/09/2021 |
Anciens postes connus de Karen-Leigh Edwards
| Sociétés | Poste | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Chief Operating Officer | - |
Formation de Karen-Leigh Edwards
| University of London | Graduate Degree |
| University of Kansas | Doctorate Degree |
| University Of The West Indies | Undergraduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OCULAR THERAPEUTIX, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
